Seadrill Limited Files its 2022 Annual Report on Form 20-F Read more about Seadrill Limited Files its 2022 Annual Report on Form 20-F
Vivoryon Therapeutics N.V. Reports Full Year 2022 Financial Results and Highlights Operational Progress Read more about Vivoryon Therapeutics N.V. Reports Full Year 2022 Financial Results and Highlights Operational Progress
ASML reports €6.7 billion net sales and €2.0 billion net income in Q1 2023 Read more about ASML reports €6.7 billion net sales and €2.0 billion net income in Q1 2023
Salmon Evolution ASA: Mandatory notification of trade Read more about Salmon Evolution ASA: Mandatory notification of trade
Salmon Evolution ASA: Key information related to the Subsequent Offering Read more about Salmon Evolution ASA: Key information related to the Subsequent Offering
Salmon Evolution ASA: Private placement successfully placed Read more about Salmon Evolution ASA: Private placement successfully placed
GENFIT Announces Publication of the 2022 Universal Registration Document and the 2022 Annual Report on Form 20-F Read more about GENFIT Announces Publication of the 2022 Universal Registration Document and the 2022 Annual Report on Form 20-F
TME Pharma Announces Successful €2 Million Financing and the End of the Convertible Bond Program With a Lock-Up of New Shares and Lock-Up of Bond Conversions Extending Financial Runway Into December 2023 Read more about TME Pharma Announces Successful €2 Million Financing and the End of the Convertible Bond Program With a Lock-Up of New Shares and Lock-Up of Bond Conversions Extending Financial Runway Into December 2023